Member Info for Sagetrade

I agree with most of this, but your naïve if you're seriously suggested Al wasn't aware of problems/delays/whatever you want to call it with the saliva LFT when selling those shares.

I have no problem with this, or with him doing so, provided he delivers on what he has promised investors. As I say, a big fortnight or so for all involved.

"Happy to hold. Share price at Christmas? How should I know? With a couple of good RNSs it'll be well North of here though that's for sure."

Correct, the key is whether we will get said news flow or not...

IMO, and only given what has been stated by the company and CEO previously, as an absolute MINIMUM they need to deliver on at least two of the following pre EOY:
- BAMS full validation
- LFT significant +ve updates (more manufacturing partners, commencing lay user study, validation for professional use)
- AVA6000 filing

It's a big fortnight or so for Mr Smith.

Having talked of transformational news flow in Q4, we have thus far only received updates on his house purchase and the fact that our covid diagnostics USP (saliva) has encountered problems and as such has effectively been parked.

Both his integrity and commercial acumen are at stake here IMO. I'll be shouted down for this, but it is my view that he 100% knew the saliva LFT wasn't going as well as his public sound bites implied when he sold some shares at c180p to fund his house purchase.

I'd be absolutely delighted to be proven wrong, but patience is wearing thin for many here. I totally agree with other posters who state how far Avacta (and the share price) have come over the last 12 months or so, as well as the fact that a number of investors are in here primarily for the oncology side of the business. However, it is a simple fact that the CEO cannot continue to get away with missing deadlines and failing to deliver on his public pronouncements, especially given the aforementioned share sale.

Pressure is on, best of luck to him and the rest of the team in delivering some tangible news flow.

Frankly you're both right...

The market opportunity is still there, no doubt. However, it's also true to state that Avacta do not currently have a Covid based diagnostic validated, let alone for sale (ELISA and BAMS research assay aside given they are very small opportunities).

I believe in the Company and what they're trying to do across all fronts, but I do think crunch time is coming in the next fortnight. The CEO cannot continue to miss deadlines and fail to deliver on soundbites made to investors and the market. There comes a point where it just totally damages his credibility and in turn investor confidence.

I sincerely hope Al proves my doubts wrong "very shortly".

Agreed JDT, he's a scientist but is he a CEO of a company that has multi billion pound potential? I think that's the key question here.

Pretty hard to disagree to be honest.

Whilst what Avacta are trying to do is no doubt potentially ground breaking for a company of their (relatively) small size, the CEO has continued to make a rod for his own back by constantly over promising and thus far under delivering on those specific promises and timelines.

If the radio silence on a number of fronts continues until Christmas, then I’m afraid serious and legitimate concerns with regards to both his integrity and commercial suitability will only get louder and more difficult to ignore.

Give it a rest Sujood - you've offered precisely ZERO informed insight on any of your posts thus far on this board, so we're now supposed to believe you're somehow in the know?!?!

What currently validated and ready to manufacture UK test would you like them to buy ?

Don't worry Si, Poundland says we're back to £2 by close, happy days.

but we're back to £2 today right?

Why did you delete your post this morning claiming this RNS would take us back to £2?

#mysticmong

RK sees it as a positive RNS? Jeez what a surprise Sujood!

I look forward to being shouted down for my “negativity”, but an underwhelming RNS for me....

People seem happy that we’re “on track” and haven’t been told that the test has failed...! It’s more jam:

- no mention of “exquisite” performance. We are now “within acceptable parameters”.... ?
- nasal swab....do we read between the lines that there has been problems with saliva?
- pilot batch looks another couple of weeks away, which with my rough maths means we’re looking at sales start of Feb....?l

Not that it matters if you’re invested for the
Medium to long term, but see the market being slightly unimpressed with where we are
too.

104 Mowzer, although I was only 33 when BAMS went into validation tbf

No, because as yet we haven't produced the first pilot batch for validation.

Regards.

Do you have a PayPal page where we can pay for private access to your unbelievable insight and mystic mong predictions?

Even better a twitter page.

Yeh, breaking about 6am this morning pal...

Good job I don’t follow him on twitter......The nonsense dressed as insight makes you want to jump off the nearest tower block.

I agree the late volume looks odd - just because no RNS this morning doesn’t mean there wasn’t a leak.

Lol PL75, that made me giggle. Spot on btw...!